Drug Profile
Research programme: nitroimidazoles - Global Alliance of TB Drug Development/University of Auckland
Alternative Names: PA-824 analogues - TB Alliance; Pretomanid analogues - TB AllianceLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Global Alliance for TB Drug Development; University of Auckland
- Developer Global Alliance for TB Drug Development; University of Auckland; University of Chicago
- Class Nitroimidazoles; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in New Zealand (PO, Suspension)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in USA (PO, Suspension)
- 31 Dec 2011 Preclinical trials in Tuberculosis in New Zealand (PO)